Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Structure Therapeutics Inc. Structure Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional American Depositary Shares June 07, 2024 From Structure Therapeutics Inc. Via GlobeNewswire Tickers GPCR Structure Therapeutics Announces Pricing of Upsized $476 Million Public Offering June 05, 2024 From Structure Therapeutics Inc. Via GlobeNewswire Tickers GPCR Structure Therapeutics Announces Proposed Public Offering of American Depositary Shares and Pre-Funded Warrants June 03, 2024 From Structure Therapeutics Inc. Via GlobeNewswire Tickers GPCR Structure Therapeutics Reports Positive Topline Data from its Phase 2a Obesity Study and Capsule to Tablet PK Study for its Oral Non-Peptide Small Molecule GLP-1 Receptor Agonist GSBR-1290 June 03, 2024 From Structure Therapeutics Inc. Via GlobeNewswire Tickers GPCR Structure Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights May 09, 2024 From Structure Therapeutics Inc. Via GlobeNewswire Tickers GPCR Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference March 08, 2024 From Structure Therapeutics Inc. Via GlobeNewswire Tickers GPCR Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Highlights March 08, 2024 From Structure Therapeutics Inc. Via GlobeNewswire Tickers GPCR Structure Therapeutics Provides Comprehensive GSBR-1290 Program Update Including Clinically Meaningful Proof-of-Concept Data From Phase 2a Clinical Study December 18, 2023 From Structure Therapeutics Inc. Via GlobeNewswire Tickers GPCR Structure Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights November 14, 2023 From Structure Therapeutics Inc. Via GlobeNewswire Tickers GPCR Structure Therapeutics Announces $300 Million Private Placement Equity Financing September 29, 2023 From Structure Therapeutics Inc. Via GlobeNewswire Tickers GPCR Structure Therapeutics Announces Positive Results from Phase 1b Clinical Study of Oral GLP-1 Receptor Agonist GSBR-1290 and Provides Program Update September 29, 2023 From Structure Therapeutics Inc. Via GlobeNewswire Tickers GPCR Structure Therapeutics Reports Second Quarter 2023 Financial Results and Recent Highlights August 10, 2023 From Structure Therapeutics Inc. Via GlobeNewswire Tickers GPCR Structure Therapeutics Appoints Ted W. Love, M.D., to Board of Directors August 03, 2023 From Structure Therapeutics Inc. Via GlobeNewswire Tickers GPCR Structure Therapeutics Announces Poster Presentations of its Oral GLP-1 Receptor Agonist GSBR-1290 at the American Diabetes Association 83rd Scientific Sessions June 07, 2023 From Structure Therapeutics Inc. Via GlobeNewswire Tickers GPCR Structure Therapeutics to Present at Jefferies Healthcare Conference May 31, 2023 From Structure Therapeutics Inc. Via GlobeNewswire Tickers GPCR Structure Therapeutics Initiates Phase 2a Study of Oral GLP-1 agonist GSBR-1290 for the Treatment of Type 2 Diabetes and Obesity May 25, 2023 From Structure Therapeutics Inc. Via GlobeNewswire Tickers GPCR Structure Therapeutics Announces Poster Presentations at the American Thoracic Society International Conference May 18, 2023 From Structure Therapeutics Inc. Via GlobeNewswire Tickers GPCR Structure Therapeutics Reports First Quarter 2023 Financial Results and Recent Highlights May 11, 2023 From Structure Therapeutics Inc. Via GlobeNewswire Tickers GPCR Structure Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights March 30, 2023 From Structure Therapeutics Inc. Via GlobeNewswire Tickers GPCR Structure Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional American Depositary Shares February 07, 2023 From Structure Therapeutics Inc. Via GlobeNewswire Tickers GPCR Structure Therapeutics Announces Pricing of Upsized Initial Public Offering February 02, 2023 From Structure Therapeutics Inc. Via GlobeNewswire Structure Therapeutics Appoints Industry Leaders Eric Dobmeier and Joanne Waldstreicher to its Board of Directors January 18, 2023 From Structure Therapeutics Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.